Growing community of inventors

Kuopio, Finland

Seppo Ylä-Herttuala

Average Co-Inventor Count = 5.29

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 20

Seppo Ylä-HerttualaKari Alitalo (2 patents)Seppo Ylä-HerttualaMarc Gregory Achen (2 patents)Seppo Ylä-HerttualaMarkku Michael Jeltsch (2 patents)Seppo Ylä-HerttualaMikko O Hiltunen (2 patents)Seppo Ylä-HerttualaHanna P Lesch (1 patent)Seppo Ylä-HerttualaTarja Hannele Tuunanen (1 patent)Seppo Ylä-HerttualaMinna Kristiina Karhinen (1 patent)Seppo Ylä-HerttualaPiia Kristiina Valonen (1 patent)Seppo Ylä-HerttualaEva Kristiina Rasanen (1 patent)Seppo Ylä-HerttualaSeppo Ylä-Herttuala (3 patents)Kari AlitaloKari Alitalo (72 patents)Marc Gregory AchenMarc Gregory Achen (24 patents)Markku Michael JeltschMarkku Michael Jeltsch (10 patents)Mikko O HiltunenMikko O Hiltunen (2 patents)Hanna P LeschHanna P Lesch (6 patents)Tarja Hannele TuunanenTarja Hannele Tuunanen (3 patents)Minna Kristiina KarhinenMinna Kristiina Karhinen (3 patents)Piia Kristiina ValonenPiia Kristiina Valonen (3 patents)Eva Kristiina RasanenEva Kristiina Rasanen (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Vegenics Pty Limited (1 from 22 patents)

2. Licentia, Ltd. (1 from 20 patents)

3. Trizell Limited (1 from 17 patents)

4. Ludwig Institute of Cancer Research (1 from 3 patents)

5. Seppo Yla-herttuala (1 from 1 patent)


3 patents:

1. 12116559 - Method of manufacturing a recombinant polypeptide

2. 8455453 - Use of VEGF-D gene to prevent restenosis

3. 6958147 - Use of VEGF-C to prevent restenosis

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/11/2025
Loading…